489 filings
SC 13G/A
Sabby Management, LLC
10 Jan 23
Cocrystal Pharma / SABBY MANAGEMENT ownership change
11:40am
8-K
COCP
Cocrystal Pharma Inc
9 Jan 23
Regulation FD Disclosure
8:00am
10-Q
2022 Q3
COCP
Cocrystal Pharma Inc
14 Nov 22
Quarterly report
8:01am
8-K
COCP
Cocrystal Pharma Inc
26 Oct 22
Enrollment Completed in Phase 1 Influenza A Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344
8:00am
8-K
COCP
Cocrystal Pharma Inc
3 Oct 22
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
COCP
Cocrystal Pharma Inc
12 Sep 22
Regulation FD Disclosure
7:00am
10-Q
2022 Q2
COCP
Cocrystal Pharma Inc
15 Aug 22
Quarterly report
8:01am
8-K
COCP
Cocrystal Pharma Inc
15 Aug 22
Cocrystal Pharma Reports Second Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs
8:00am
4
Anthony J Japour
3 Aug 22
Cocrystal Pharma / Anthony J Japour ownership change
4:51pm
4
Martin James Joseph
3 Aug 22
Cocrystal Pharma / James Joseph Martin ownership change
4:03pm
4
Pfenniger Richard C JR
3 Aug 22
Cocrystal Pharma / RICHARD C PFENNIGER JR ownership change
4:03pm
4
COCP
Cocrystal Pharma Inc
3 Aug 22
Cocrystal Pharma / PHILLIP MD ET AL FROST ownership change
4:03pm
4
COCP
Cocrystal Pharma Inc
3 Aug 22
Cocrystal Pharma / Steven D Rubin ownership change
4:02pm
4
Kornberg Roger D.
3 Aug 22
Cocrystal Pharma / Roger D. Kornberg ownership change
4:02pm
4
Lee Sam
3 Aug 22
Cocrystal Pharma / Sam Lee ownership change
4:02pm
8-K
COCP
Cocrystal Pharma Inc
29 Jul 22
Departure of Directors or Certain Officers
5:00pm
8-K
COCP
Cocrystal Pharma Inc
20 May 22
Submission of Matters to a Vote of Security Holders
8:30am
8-K
COCP
Cocrystal Pharma Inc
19 May 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am
10-Q
2022 Q1
COCP
Cocrystal Pharma Inc
11 May 22
Quarterly report
8:30am
8-K
COCP
Cocrystal Pharma Inc
11 May 22
Cocrystal Pharma Reports First Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs and Milestones
8:30am